IP Library › Granted Patent US 9,708,219
Granted Patent B2
US 9,708,219 · App. 14/223,787 · Granted Jul 18, 2017

Metal oxide activated cement

Inventor: Trevor Cyril Waters (Sydney, AU)
C04B28/008C04B28/005Y02P40/165
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,708,219
App. No.
14/223,787
Granted
Jul 18, 2017
Kind
B2
Abstract

A cement including: an alkali silicate; an organic silicate; a compound selected from a group consisting of Pozzolanic compounds and synthetic Pozzolanic substitutes; a metal oxide; an activator.

Claims (16)

1. A process for making a cement, containing a naturally occurring silicate bound in an organic binder and a metal oxide, comprising steps of:

dissolving the binder using a chemical activator;

reducing particle size of the binder to enable the silicate to react with other components of the cement;

enabling the silicate to serve as a center for crystal growth;

wherein an effective amount of the chemical activator is added to dissolve the binder sufficiently, in order to ensure that that the cement is a structural load bearing cement.

2. The process recited in claim 1 , wherein the chemical activator is selected from a group consisting of: a ligand, a chelate, a mineral acid, an organic acid, an amino acid derivative, an alkali, an amphoteric compound, a biochemical, a salt, and an etching agent.

3. The process recited in claim 2 , wherein the ligand is pyridine N oxide.

4. The process recited in claim 2 , wherein the chelate is selected from a group consisting of: EDTA, PBTC, HEDTA, DTPA, oxyquinoline, and oxalic acid.

5. The process recited in claim 2 , wherein the mineral acid is boric acid.

6. The process recited in claim 2 , wherein the organic acid is selected from a group consisting of: DL-malic acid, a carboxylic acid, citric acid, acetic acid, formic acid, lactic acid, DHBA, gallic acid, and acetylacetone.

7. The process recited in claim 2 , wherein the amino acid is selected from a group consisting of: L-histidine, and L-phenylalanine.

8. The process recited in claim 2 , wherein the biochemical is selected from a group consisting of: dopamine, and DOPAC.

9. The process recited in claim 2 , wherein the salt is monosodium glutamate.

10. The process recited in claim 2 , wherein the etching agent is selected from a group consisting of: ammonium difluoride, ammonium fluoride, potassium bifluoride, phosphoric acid, and phosphorous acid.

11. The process recited in claim 2 , wherein the metal oxide is a primary metal oxide selected from a group consisting of: aluminum oxide, calcium oxide, magnesium oxide, and iron oxide.

12. The process recited in claim 2 , wherein the metal oxide is a secondary metal oxide selected from a group consisting of: titanium dioxide (titanium white), zinc oxide (neutral white), iron oxide (mars black), hydrated iron oxide (yellow ochre), and anhydrous iron oxide (red ochre).

Priority Claims (1)
AU 2013901015 · Mar 24, 2013 · national
Continuity (2)
Provisional Application 61810010 · Apr 9, 2013
Related Publication 20140284309A1 · Sep 25, 2014